PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Clinics in Liver Disease - Tập 4 - Trang 753-763 - 2000
Emmanuel Jacquemin

Tài liệu tham khảo

Arnell, 1997, Progressive familial intrahepatic cholestasis (PFIC): Evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21–22, Hum Genet, 100, 378, 10.1007/s004390050519 Bezerra, 1999, Intrahepatic cholestasis: Order out of chaos, Gastroenterology, 117, 1496, 10.1016/S0016-5085(99)70302-1 Beuers, 1993, Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++, mechanisms defective in cholestasis, J Clin Invest, 93, 2984, 10.1172/JCI116921 Bourke, 1996, Byler-like familial cholestasis in an extended kindred, Arch Dis Child, 75, 223, 10.1136/adc.75.3.223 Bull, 1997, Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity, Hepatology, 26, 155, 10.1002/hep.510260121 Bull, 1998, A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis, Nat Genet, 18, 219, 10.1038/ng0398-219 Carlton, 1995, Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21–q22, the benign recurrent intrahepatic cholestasis region, Hum Mol Genet, 4, 1049, 10.1093/hmg/4.6.1049 Clayton, 1965, Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred, J Pediatr, 67, 1025, 10.1016/S0022-3476(65)82107-2 Clayton, 1969, Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred, American Journal of Diseases of Children, 117, 112, 10.1001/archpedi.1969.02100030114014 de Vree, 1998, Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis, Proc Natl Acad Sci U S A, 95, 282, 10.1073/pnas.95.1.282 de Vree, 1998, Rapid correction of mdr2 deficiency by transplantation of MDR3 transgenic hepatocytes, Hepatology, 28, 387A Deleuze, 1996, Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis, Hepatology, 23, 904, 10.1002/hep.510230435 Emond, 1995, Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease), J Pediatr Surg, 30, 1635, 10.1016/0022-3468(95)90440-9 Estella, 1994, Histologic pathology of the liver in progressive familial intrahepatic cholestasis, J Pediatr Gastroenterol Nutr, 18, 128, 10.1097/00005176-199402000-00002 Gerloff, 1998, The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver, J Biol Chem, 273, 10046, 10.1074/jbc.273.16.10046 Houwen, 1994, Genome screening by searching for shared fragments: Mapping of a gene for benign recurrent intrahepatic cholestasis, Nat Genet, 8, 380, 10.1038/ng1294-380 Jacquemin, 1993, Ursodeoxycholic acid improves ethinyl estradiol induced-cholestasis in the rat, Eur J Clin Invest, 23, 794, 10.1111/j.1365-2362.1993.tb00733.x Jacquemin, 1994, Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease), Eur J Pediatr, 153, 424, 10.1007/BF01983406 Jacquemin, 1994, A new cause of progressive intrahepatic cholestasis: 3β-Hydroxy-C27-steroid dehydrogenase/isomerase deficiency, J Pediatr, 125, 379, 10.1016/S0022-3476(05)83280-9 Jacquemin, 1997, Ursodeoxycholic therapy in pediatric patients with progressive familial intrahepatic cholestasis, Hepatology, 25, 519, 10.1002/hep.510250303 Jacquemin, 1998, MDR3 deficiency: Progressive familial intrahepatic cholestasis (PFIC) due to MDR3 gene mutations, Hepatology, 28, 316A Jacquemin, 1999, Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy, Lancet, 353, 210, 10.1016/S0140-6736(05)77221-4 Jacquemin, 1999, Genetic basis of progressive familial intrahepatic cholestasis, J Hepatol, 31, 377, 10.1016/S0168-8278(99)80240-2 Jacquemin, 1999, Progressive familial intrahepatic cholestasis, J Gastroenterol Hepatol, 14, 594, 10.1046/j.1440-1746.1999.01921.x Jansen, 1998, The canalicular bile salt exporting protein BSEP is not expressed in patients with progressive familial intrahepatic cholestasis type 2, Hepatology, 28, 498A Jansen, 1999, Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis, Gastroenterology, 117, 1370, 10.1016/S0016-5085(99)70287-8 Linarelli, 1972, Byler's disease: Fatal intrahepatic cholestasis, J Pediatr, 81, 484, 10.1016/S0022-3476(72)80174-4 Lincke, 1991, Structure of the human MDR3 gene and physical mapping of the human MDR locus, J Biol Chem, 266, 5303, 10.1016/S0021-9258(19)67788-4 Maggiore, 1987, Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis, J Pediatr, 111, 251, 10.1016/S0022-3476(87)80079-3 Maggiore, 1991, Diagnostic value of serum γ-glutamyl transpeptidase activity in liver diseases in children, J Pediatr Gastroenterol Nutr, 12, 21, 10.1097/00005176-199101000-00005 Mutero, 1998, Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1, Hepatology, 28, 530A Naveh, 1997, Progressive intrahepatic cholestasis among the Arab population of Israel, J Pediatr Gastroenterol Nutr, 24, 548, 10.1097/00005176-199705000-00011 Palma, 1992, Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy, Hepatology, 15, 1043, 10.1002/hep.1840150612 Poupon, 1993, Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy, Hepatology, 17, 599, 10.1002/hep.1840170412 Reutz, 1994, Phosphatidylcholine translocase: A physiological role for the mdr2 gene, Cell, 77, 1071, 10.1016/0092-8674(94)90446-4 Setchell, 1988, Δ4-3 oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis, J Clin Invest, 82, 2148, 10.1172/JCI113837 Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 Smit, 1994, Tissue distribution of the human MDR3 P-glycoprotein, Lab Invest, 71, 638 Smith, 1994, The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice, FEBS Lett, 354, 263, 10.1016/0014-5793(94)01135-4 Smith, 1998, Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidycholine excretion absent in mdr2 (−/−) mice, Hepatology, 28, 530, 10.1002/hep.510280234 Soubrane, 1990, Orthotopic liver transplantation for Byler disease, Transplantation, 50, 804, 10.1097/00007890-199011000-00012 Strautnieks, 1997, Identification of a locus for progressive familial intrahepatic cholestasis (PFIC2) on chromosome 2q24, Am J Hum Genet, 61, 630, 10.1086/515501 Strautnieks, 1998, A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis, Nat Genet, 20, 233, 10.1038/3034 Tazawa, 1985, Bile acids profiles in siblings with progressive intrahepatic cholestasis: Absence of biliary chenodeoxycholate, J Pediatr Gastroenterol Nutr, 4, 32, 10.1097/00005176-198502000-00007 Trauner, 1998, Molecular pathogenesis of cholestasis, N Engl J Med, 339, 1217, 10.1056/NEJM199810223391707 van Nieuwkerk, 1996, Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 p-glycoprotein gene, Gastroenterology, 111, 165, 10.1053/gast.1996.v111.pm8698195 Whitington, 1988, Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis, Gastroenterology, 95, 130, 10.1016/0016-5085(88)90301-0 Whitington, 1994, Clinical and biochemical findings in progressive familial intrahepatic cholestasis, J Pediatr Gastroenterol Nutr, 18, 134, 10.1097/00005176-199402000-00003 Williams, 1972, Progressive familial cholestatic cirrhosis and bile acid metabolism, J Pediatr, 81, 493, 10.1016/S0022-3476(72)80175-6 Winklhofer-Roob, 1992, Progressive idiopathic cholestasis presenting with profuse watery diarrhea and recurrent infections (Byler's disease), Acta Paediatr, 81, 637, 10.1111/j.1651-2227.1992.tb12320.x